Blood storage technology maker Hemerus Medical this week touted its 1st regulatory win, but it’s not the one that will seal the deal on a $27 million buyout by Haemonetics (NYSE:HAE).
The St. Paul, Minn.-based company won CE Mark approval in the European Union for its Solx red blood cell storage system, which was developed in collaboration with the U.S. Army and the University of Cincinnati.